Monday, November 10, 2025
Larimar Therapeutics, Inc. Updates on Nomlabofusp Development
On November 10, 2025, Larimar Therapeutics, Inc. provided updates on its nomlabofusp clinical program and future plans.
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.